1. Dose adjustment of carboplatin in patients on hemodialysis
   Achuta K. Guddati et al, 2014, Med Oncol CrossRef
2. Advanced Thymic Cancer Treated with Carboplatin and Paclitaxel in a Patient Undergoing Hemodialysis
   Satoru Miura et al, 2015, Intern. Med. CrossRef
3. Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report
   Takuma Wada et al, 2016 CrossRef
4. Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report
   Masahiro Kondo et al, 2018, J Pharm Health Care Sci CrossRef
5. Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure
   Ken-ichi Fujita et al, 2019, CDM CrossRef
6. Cancer screening and treatment in patients with end-stage renal disease: remaining issues in the field of onco-nephrology
   Yuichiro Kitai et al, 2016, Ren Replace Ther CrossRef
7. Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United Kingdom
   Shelby Barnett et al, 2020, Br J Clin Pharmacol CrossRef
8. Chemotherapy in chronic kidney disease and dialysis
   SABINE KARAM et al, 2020 CrossRef
9. MWCNT modified glassy carbon electrode in presence of cationic surfactant for the electro-analysis of Paclitaxel
   Jayant I. Gowda et al, 2021, Results in Chemistry CrossRef
10. Treatment of advanced ovarian cancer with carboplatin and paclitaxel in a patient undergoing hemodialysis: Case report and literature review
    Qing Yang et al, 2022, Hemodialysis International CrossRef
11. Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis
    Nan Zhang et al, 2023, OTT CrossRef